The functional activity of IL-6 is dysregulated in a variety of malignancies, including breast, lung, pancreatic, colorectal, gastric, blood, and skin cancers, and high serum IL-6 levels are associated with bad prognosis in cancer patients [40,41,42]. The gene discussed is IL6; the disease is cancer.